Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2003
03/27/2003WO2002017880A3 Nitric oxide-producing hydrogel materials
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002004006A3 Method for improving the efficacy of artificial insemination of non-human animals
03/27/2003US20030060629 Pyrazine derivatives as modulators of tyrosine kinases
03/27/2003US20030060627 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060455 Treating lung damage from smoke, endometriosis, Behcet's disease, ankylosing spondylitis, cancer, Lyme disease, and/or restenosis following agioplasty with 1-(4-t-butyl-phenyl)-3-(4-(6-morpholin-4-ylmethyl-peperidin-yl)naphthalen-1 -yl)-urea
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060399 A heat shock protein 20 (HSP20)-derived polypeptides for treating or inhibiting smooth muscle vasospasm, smooth muscle cell proliferation, migration, and vasoconstriction
03/27/2003US20030059877 Human cystine knot polypeptide
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059456 Intravaginal drug delivery devices for the administration of an antimicrobial agent
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003CA2460885A1 Composition comprising cysteamine for improving lactation in dairy animals
03/27/2003CA2460620A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003CA2460440A1 Salicylic acid salts, processes for preparing them and their use as pharmaceutical compositions
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460319A1 Lpa receptor agonists and antagonists and methods of use
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/26/2003EP1294928A1 Screening method for modulators of suv39h2-methyltransferase
03/26/2003EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability
03/26/2003EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294887A1 Insulin homolog polypeptide zins4
03/26/2003EP1294885A2 B7-like molecules and uses thereof
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294868A2 Adenylyl and guanylyl cyclases
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294739A1 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity
03/26/2003EP1294729A1 2-aminoalkyl-thieno[2,3-d]pyrimidines
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294719A1 Melanocortin receptor ligands
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294396A2 Contraceptive vaccines for pest control
03/26/2003EP1294392A2 Materials and methods relating for the treatment and diagnosis of pre-eclampsia
03/26/2003EP1294389A1 THERAPEUTICAL USE OF i SOPHORA FLAVESCENS /i OR i SOPHORA SUBPROSTRATA /i EXTRACTS
03/26/2003EP1294388A1 EXTRACTS FROM i SOPHORA /i SPECIES, METHOD FOR PRODUCING THE SAME AND THEIR USE
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1212315B1 Novel chalcones
03/26/2003EP1212311B1 Chalcone coumarins
03/26/2003EP1146873A4 Anti-androgens and methods for treating disease
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1064012A4 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
03/26/2003EP0833658B1 Inhibin compositions and methods of enhancing production performance
03/26/2003CN1404867A Chinese medicine for treating hyperplasia of mammary glands
03/26/2003CN1404866A Ru'an oral liquor
03/26/2003CN1404837A Natural oral liquor for treatment of women's climacteric syndrome
03/26/2003CN1103756C Estrogenic agents
03/26/2003CN1103595C Chinese medicine preparation for postpartum recovery and its preparing process
03/26/2003CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM
03/26/2003CN1103589C Method for modulating human sexual response
03/25/2003US6538034 Methods of treating or preventing weight gain, obesity, and related disorders
03/25/2003US6538026 A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538000 9-(3-chloro-4-hydroxyphenyl)-5,6,7,9-tetrahydropyrazolo(5,1-b) quinazoline-8(4H)-one;for cardiovascular disorders
03/25/2003US6537995 Heterocyclic carboxamides
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537970 The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.
03/25/2003US6537966 Follistatin-3
03/25/2003US6537538 Polystyrene sulfonate inhibits Trichomonas, Gardnerella, and other vaginitis/vaginosis-causing bacteria
03/25/2003CA2107961C Injectable mesna solutions
03/21/2003WO2002022555A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003022864A1 17alpha-hydroxy-14beta-steroids with hormonal effect
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022310A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
03/20/2003WO2003022303A2 Use of hcg and lh in controlled ovarian hyperstimulation
03/20/2003WO2003022302A2 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
03/20/2003WO2003022301A2 Use of lh in controlled ovarian hyperstimulation
03/20/2003WO2003022297A1 Biodegradable implant comprising a polylactide polymer and a lh-rh analogue
03/20/2003WO2003022278A1 Contraceptives
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022263A1 Pharmaceutical composition comprising gamma-butyrobetaine for stimulating the sexual activity and potency
03/20/2003WO2003022262A1 Pharmaceutical composition comprising gamma-butyrobetaine
03/20/2003WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003WO2002102808A3 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002094342A3 Compositions for protein delivery via the pulmonary route
03/20/2003WO2002092102A3 Treatment of conditions relating to hormone deficiencies by administration of progestins
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002066040A8 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002020736A3 Proteases
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055098 Method of treatment
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 557